GV (Google Ventures)
GV (formerly Google Ventures) is the venture capital arm of Alphabet Inc. With a dedicated life sciences practice, GV invests in transformative healthcare and life sciences companies, bringing deep technical expertise and operational support from Google's ecosystem to portfolio companies.
Website
https://www.gv.comLocation
Mountain View, California, USA
Founded
2009
AUM
$8B+
Investment Range
$100K - $250M+
Portfolio Companies
3
Focus
cvc
Fund Stages
seed, series-a, series-b, series-c, growth
Investment Thesis
GV invests in founders who are building transformative companies in life sciences and healthcare. They focus on applying technology and engineering approaches to solve fundamental healthcare challenges, from drug discovery and genomics to digital health and healthcare delivery.
Team
Partners / Managing Directors (Health & Bio Focus)
- Krishna Yeshwant, MD - General Partner, Life Sciences
- Cathy Friedman - Partner, Life Sciences
- David Scheinberg - Partner, Life Sciences
Other Key Team Members
- David Krane - CEO & Managing Partner
- Tom Hulme - General Partner
Focus Areas
- Genomics and sequencing
- Drug discovery and development
- Diagnostics
- Digital health
- Healthcare AI/ML
- Medical devices
- Synthetic biology
Notable Exits
- Flatiron Health - Acquired by Roche (2018, $1.9B)
- Foundation Medicine - Acquired by Roche (2018, $5.3B)
- 23andMe - SPAC (2021)
- Tempus - IPO (2024)
Sources
- https://www.gv.com
- https://www.gv.com/team
- Crunchbase
- PitchBook
- Company announcements
Portfolio Companies
| Name | Location | Founded | Categories |
|---|---|---|---|
| DNAnexus | Mountain View, California, USA | 2009 | genomicscloud-platform+3 |
| Tempus AI | Chicago, Illinois, USA | 2015 | genomics-sequencingai-drug-discovery+4 |
| Foundation Medicine | Cambridge, Massachusetts, USA | 2010 | genomics-sequencingdiagnostics+3 |